Generali Asset Management SPA SGR
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 2046751
TRIESTE, L6
Position in ALNY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$541,552
-$514,915 QoQ
Shares Held
1,799
-43.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#470
of 780 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Generali Asset Management SPA SGR holds $13,640,959 across 6 Biotechnology names. ALNY ranks #4 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,161 | $7,530,923 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,685 | $4,791,904 | |
| 3 | INCY |
Incyte Corp
|
6,140 | $696,030 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1,799 | $541,552 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,425 | $79,899 | |
| 6 | BNTX |
BioNTech SE
|
7 | $651 |
All Filings in ALNY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $541,552 | 1,799 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,056,467 | 3,193 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $19,882 | 50 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,474,704 | 3,234 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $16,304 | 50 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $13,501 | 50 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,471 | 53 | Shares | Sole | 2025-05-29 | |
| No filing history on record for this holder in this stock. | ||||||